Bartlett & Co’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $111M | Buy |
383,241
+1,551
| +0.4% | +$423K | 1.79% | 14 |
|
|
2023
Q3 | $103M | Buy |
381,690
+676
| +0.2% | +$169K | 1.84% | 12 |
|
|
2023
Q2 | $84.6M | Sell |
381,014
-1,510
| -0.4% | -$350K | 1.46% | 18 |
|
|
2023
Q1 | $92.5M | Sell |
382,524
-516
| -0.1% | -$127K | 1.79% | 11 |
|
|
2022
Q4 | $101M | Buy |
383,040
+355
| +0.1% | +$95.2K | 2.02% | 10 |
|
|
2022
Q3 | $86.3M | Sell |
382,685
-1,091
| -0.3% | -$264K | 1.85% | 10 |
|
|
2022
Q2 | $93.4M | Sell |
383,776
-7,832
| -2% | -$1.92M | 1.89% | 10 |
|
|
2022
Q1 | $94.7M | Buy |
391,608
+1,704
| +0.4% | +$392K | 1.66% | 12 |
|
|
2021
Q4 | $87.7M | Buy |
389,904
+2,321
| +0.6% | +$490K | 1.49% | 17 |
|
|
2021
Q3 | $82.4M | Sell |
387,583
-147
| -0% | -$33.8K | 1.57% | 15 |
|
|
2021
Q2 | $94.5M | Sell |
387,730
-2,793
| -0.7% | -$687K | 1.8% | 10 |
|
|
2021
Q1 | $97.2M | Buy |
390,523
+4,114
| +1% | +$982K | 1.95% | 10 |
|
|
2020
Q4 | $88.8M | Buy |
386,409
+2,650
| +0.7% | +$611K | 1.9% | 10 |
|
|
2020
Q3 | $97.5M | Sell |
383,759
-764
| -0.2% | -$189K | 2.29% | 7 |
|
|
2020
Q2 | $90.7M | Buy |
384,523
+319
| +0.1% | +$72.8K | 2.37% | 6 |
|
|
2020
Q1 | $77.9M | Buy |
+384,204
| New | +$83.9M | 2.37% | 6 |
|
|
2019
Q3 | $75.6M | Buy |
390,657
+111,682
| +40% | +$21.4M | 1.98% | 12 |
|
|
2019
Q2 | $51.4M | Sell |
278,975
-1,710
| -0.6% | -$306K | 1.92% | 12 |
|
|
2019
Q1 | $53.3M | Sell |
280,685
-1,839
| -0.7% | -$351K | 2.04% | 11 |
|
|
2018
Q4 | $55M | Sell |
282,524
-4,000
| -1% | -$780K | 2.35% | 8 |
|
|
2018
Q3 | $59.4M | Sell |
286,524
-896
| -0.3% | -$177K | 2.23% | 9 |
|
|
2018
Q2 | $53.1M | Sell |
287,420
-1,105
| -0.4% | -$195K | 2.16% | 10 |
|
|
2018
Q1 | $49.2M | Buy |
288,525
+2,772
| +1% | +$509K | 2.03% | 11 |
|
|
2017
Q4 | $49.7M | Sell |
285,753
-3,635
| -1% | -$643K | 1.98% | 12 |
|
|
2017
Q3 | $54M | Buy |
289,388
+671
| +0.2% | +$119K | 2.26% | 7 |
|
|
2017
Q2 | $49.7M | Sell |
288,717
-1,761
| -0.6% | -$286K | 2.24% | 8 |
|
|
2017
Q1 | $47.7M | Sell |
290,478
-3,371
| -1% | -$560K | 2.17% | 11 |
|
|
2016
Q4 | $43M | Buy |
293,849
+6,277
| +2% | +$945K | 2.03% | 13 |
|
|
2016
Q3 | $48M | Sell |
287,572
-2,302
| -0.8% | -$389K | 2.31% | 8 |
|
|
2016
Q2 | $44.1M | Sell |
289,874
-528
| -0.2% | -$82.1K | 2.18% | 10 |
|
|
2016
Q1 | $43.5M | Buy |
290,402
+1,984
| +0.7% | +$295K | 2.18% | 11 |
|
|
2015
Q4 | $46.8M | Buy |
288,418
+1,991
| +0.7% | +$313K | 2.41% | 9 |
|
|
2015
Q3 | $39.6M | Buy |
286,427
+6,938
| +2% | +$1.09M | 2.17% | 11 |
|
|
2015
Q2 | $42.9M | Buy |
279,489
+10,222
| +4% | +$1.64M | 2.15% | 9 |
|
|
2015
Q1 | $43M | Buy |
269,267
+25,315
| +10% | +$3.99M | 2.14% | 10 |
|
|
2014
Q4 | $38.9M | Sell |
243,952
-6,229
| -2% | -$971K | 1.87% | 17 |
|
|
2014
Q3 | $35.1M | Sell |
250,181
-2,519
| -1% | -$329K | 1.7% | 19 |
|
|
2014
Q2 | $29.9M | Buy |
252,700
+12,625
| +5% | +$1.46M | 1.44% | 27 |
|
|
2014
Q1 | $29.6M | Sell |
240,075
-7,411
| -3% | -$899K | 1.47% | 24 |
|
|
2013
Q4 | $28.2M | Sell |
247,486
-6,760
| -3% | -$769K | 1.41% | 26 |
|
|
2013
Q3 | $28.5M | Sell |
254,246
-6,570
| -3% | -$712K | 1.54% | 23 |
|
|
2013
Q2 | $25.7M | Buy |
+260,816
| New | +$27.1M | 1.42% | 26 |
|
Other funds holding AMGN
Bartlett & Co's AMGN Position: Q4 2023 in Review
Bartlett & Co increased its Amgen (AMGN) stake by 0.41% in Q4 2023, buying an estimated $423K and bringing the position to 383,241 shares worth $111M. The position accounts for 1.79% of the portfolio, ranked #14.
Bartlett & Co first reported a position in AMGN in Q2 2013 and has held it in 42 quarters since. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.
- Bartlett & Co held 383,241 shares of Amgen worth $111M as of Q4 2023.
- Bartlett & Co bought 1,551 Amgen shares in Q4 2023, an estimated $423K.
- Amgen made up 1.79% of Bartlett & Co's portfolio in Q4 2023, its #14 holding.
- Bartlett & Co first reported a position in Amgen in Q2 2013 and has held it in 42 quarters since.
- 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.